Albring M - Search Results

1

Treatment of patients with peripheral arterial occlusive disease Fontaine stage III and IV with intravenous iloprost: an open study in 900 patients.

Staben P, Albring M. Staben P, et al. Among authors: albring m. Prostaglandins Leukot Essent Fatty Acids. 1996 May;54(5):327-33. doi: 10.1016/s0952-3278(96)90046-0. Prostaglandins Leukot Essent Fatty Acids. 1996. PMID: 8832761 Clinical Trial.

2

A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.

Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K. Bannemerschult R, et al. Among authors: albring m. Contraception. 1997 Nov;56(5):285-90. doi: 10.1016/s0010-7824(97)00157-1. Contraception. 1997. PMID: 9437556 Clinical Trial.

3

Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.

Brill K, Norpoth T, Schnitker J, Albring M. Brill K, et al. Among authors: albring m. Contraception. 1991 Feb;43(2):101-10. doi: 10.1016/0010-7824(91)90037-g. Contraception. 1991. PMID: 2040166 Clinical Trial.

4

Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents.

Brill K, Schnitker J, Albring M. Brill K, et al. Among authors: albring m. Adv Contracept. 1994 Dec;10(4):237-47. Adv Contracept. 1994. PMID: 7740990 Clinical Trial.

5

[Genetic technology and the investigative pharmaceutical industry. Prospects for the first decade of a new century].

Albring M, Czempiel W, Fischer EP. Albring M, et al. Med Monatsschr Pharm. 1995 Mar;18(3):57-67. Med Monatsschr Pharm. 1995. PMID: 7723708 German. No abstract available.

6

Long-term experience with a low-dose oral contraceptive.

Brill K, Schnitker J, Albring M. Brill K, et al. Among authors: albring m. Gynecol Endocrinol. 1990 Dec;4(4):277-86. doi: 10.3109/09513599009024982. Gynecol Endocrinol. 1990. PMID: 2150581 Free article. Clinical Trial.

7

[Clinical experiences with femovan (Gynera)].

Brill K, Düsterberg B, Albring M. Brill K, et al. Among authors: albring m. Ther Umsch. 1990 Dec;47(12):958-65. Ther Umsch. 1990. PMID: 2096480 Clinical Trial. German.

8

Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements.

Siekmann L, Siekmann A, Bidlingmaier F, Brill K, Albring M. Siekmann L, et al. Among authors: albring m. Eur J Endocrinol. 1998 Aug;139(2):167-77. doi: 10.1530/eje.0.1390167. Eur J Endocrinol. 1998. PMID: 9724072 Clinical Trial.

9

[The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].

Gollnick H, Albring M, Brill K. Gollnick H, et al. Among authors: albring m. Ann Endocrinol (Paris). 1999 Sep;60(3):157-66. Ann Endocrinol (Paris). 1999. PMID: 10520404 Clinical Trial. French.

10

[Activation of blood coagulation and fibrinolysis after angiocardiography with ionic and non-ionic contrast media].

Winkler UH, Park JW, Weber S, Kothe A, Schnitker J, Behrends-Steins B, Albring M. Winkler UH, et al. Among authors: albring m. Rofo. 1997 Jun;166(6):539-43. doi: 10.1055/s-2007-1015473. Rofo. 1997. PMID: 9273008 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters